Why is Clinitech Lab falling/rising?

As of 24-Sep, Clinitech Laboratory Ltd is experiencing a decline in its stock price, currently at 44.00, which reflects a decrease of 0.8 or 1.79%. The stock has underperformed its sector by 1.17% today, and it has shown erratic trading patterns, not trading on 3 out of the last 20 days. Additionally, the stock's delivery volume has decreased by 28.57% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has dropped by 4.43%, and its year-to-date performance shows a significant decline of 44.20%. Unfortunately, there is no available information regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, the Sensex has shown a slight decline of 1.18% over the past week, which suggests that the overall market sentiment is somewhat negative. However, Clinitech's performance is notably worse than the benchmark, indicating that specific issues within the company are contributing to its underperformance. While the Sensex has gained 4.58% year-to-date, Clinitech's substantial decline highlights a stark contrast, suggesting that investors may be losing confidence in the company's prospects compared to the broader market.